Literature DB >> 9926916

Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation.

J Zwicker1, S Brüsselbach, K U Jooss, A Sewing, M Behn, F C Lucibello, R Müller.   

Abstract

Although cyclin D1 plays a major role during cell cycle progression and is involved in human tumourigenesis, its domain structure is still poorly understood. In the present study, we have generated a series of cyclin D1 N- and C-terminal deletion constructs. These mutants were used to define the domains required for transformation of rat embryonal fibroblasts (REF) in cooperation with activated Ha-ras and and to establish correlations with defined biochemical properties of cyclin D1. Protein binding and REF assays showed that the region of the cyclin box required for the interaction with CDK4 as well as C-terminal sequences determining protein stability were crucial for transformation. Surprisingly, however, the N-terminal deletion of 20 amino acids which impaired pRb kinase activity did not affect the transforming ability of cyclin D1. Likewise, no effect on transformation was observed with mutants defective in p21CIP interaction. These observations argue against a crucial role of pRb inactivation or p21CIP squelching in cyclin D1-mediated transformation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9926916     DOI: 10.1038/sj.onc.1202286

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Zinc finger transcription factor INSM1 interrupts cyclin D1 and CDK4 binding and induces cell cycle arrest.

Authors:  Tao Zhang; Wei-Dong Liu; Nicolle A Saunee; Mary B Breslin; Michael S Lan
Journal:  J Biol Chem       Date:  2009-01-05       Impact factor: 5.157

2.  Co-expressed Cyclin D variants cooperate to regulate proliferation of germline nuclei in a syncytium.

Authors:  Gunasekaran Subramaniam; Coen Campsteijn; Eric M Thompson
Journal:  Cell Cycle       Date:  2015-04-30       Impact factor: 4.534

Review 3.  Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.

Authors:  Chenguang Wang; Michael P Lisanti; D Joshua Liao
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

4.  The Drosophila cyclin D-Cdk4 complex promotes cellular growth.

Authors:  S A Datar; H W Jacobs; A F de la Cruz; C F Lehner; B A Edgar
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

5.  Maintenance of motor neuron progenitors in Xenopus requires a novel localized cyclin.

Authors:  Jun-An Chen; Sin-Tak Chu; Enrique Amaya
Journal:  EMBO Rep       Date:  2007-02-16       Impact factor: 8.807

6.  Cyclin D1 promotes BRCA2-Rad51 interaction by restricting cyclin A/B-dependent BRCA2 phosphorylation.

Authors:  C Chalermrujinanant; W Michowski; G Sittithumcharee; F Esashi; S Jirawatnotai
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

7.  RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.

Authors:  Yikun Cheng; Bin Yang; Yanfeng Xi; Xing Chen
Journal:  Tumour Biol       Date:  2016-09-20

8.  Identification of the cyclin D1b mRNA variant in mouse.

Authors:  Jack Wu; Si-hung Wu; Aliccia Bollig; Archana Thakur; D Joshua Liao
Journal:  Mol Biol Rep       Date:  2008-04-30       Impact factor: 2.316

9.  Novel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phase influencing cell migration and second phase directing cell proliferation.

Authors:  Venkatesh Kundumani-Sridharan; Dong Van Quyen; Jaganathan Subramani; Nikhlesh K Singh; Y Eugene Chin; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2012-05-06       Impact factor: 5.157

Review 10.  Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation.

Authors:  Michael S Lan; Mary B Breslin
Journal:  FASEB J       Date:  2009-02-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.